Camadan, Y.A. (2026) “Refractory thrombocytopenia after 177Lu-PSMA therapy: bone marrow infiltration (myelophthisis) versus treatment toxicity”, Scientific Reports in Medicine, 3(1), pp. 39–46. doi:10.37609/srinmed.63.